Persisting with prevention: The importance of adherence for HIV prevention

Helen A. Weiss, Judith N. Wasserheit, Ruanne V. Barnabas, Richard J. Hayes, Laith Aburaddad

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

Background. Only four out of 31 completed randomized controlled trials (RCTs) of HIV prevention strategies against sexual transmission have shown significant efficacy. Poor adherence may have contributed to the lack of effect in some of these trials. In this paper we explore the impact of various levels of adherence on measured efficacy within an RCT. Analysis. We used simple quantitative methods to illustrate the impact of various levels of adherence on measured efficacy by assuming a uniform population in terms of sexual behavior and the binomial model for the transmission probability per partnership. At 100% adherence the measured efficacy within an RCT is a reasonable approximation of the true biological efficacy. However, as adherence levels fall, the efficacy measured within a trial substantially under-estimates the true biological efficacy. For example, at 60% adherence, the measured efficacy can be less than half of the true biological efficacy. Conclusion. Poor adherence during a trial can substantially reduce the power to detect an effect, and improved methods of achieving and maintaining high adherence within trials are needed. There are currently 12 ongoing HIV prevention trials, all but one of which require ongoing user-adherence. Attention must be given to methods of maximizing adherence when piloting and designing RCTs and HIV prevention programmes.

Original languageEnglish
Article number8
JournalEmerging Themes in Epidemiology
Volume5
DOIs
Publication statusPublished - 2008
Externally publishedYes

Fingerprint

Randomized Controlled Trials
HIV
Statistical Models
Sexual Behavior
Population

ASJC Scopus subject areas

  • Epidemiology

Cite this

Persisting with prevention : The importance of adherence for HIV prevention. / Weiss, Helen A.; Wasserheit, Judith N.; Barnabas, Ruanne V.; Hayes, Richard J.; Aburaddad, Laith.

In: Emerging Themes in Epidemiology, Vol. 5, 8, 2008.

Research output: Contribution to journalArticle

Weiss, Helen A. ; Wasserheit, Judith N. ; Barnabas, Ruanne V. ; Hayes, Richard J. ; Aburaddad, Laith. / Persisting with prevention : The importance of adherence for HIV prevention. In: Emerging Themes in Epidemiology. 2008 ; Vol. 5.
@article{3fcfaabb274a4a70aa3096bc6216da3f,
title = "Persisting with prevention: The importance of adherence for HIV prevention",
abstract = "Background. Only four out of 31 completed randomized controlled trials (RCTs) of HIV prevention strategies against sexual transmission have shown significant efficacy. Poor adherence may have contributed to the lack of effect in some of these trials. In this paper we explore the impact of various levels of adherence on measured efficacy within an RCT. Analysis. We used simple quantitative methods to illustrate the impact of various levels of adherence on measured efficacy by assuming a uniform population in terms of sexual behavior and the binomial model for the transmission probability per partnership. At 100{\%} adherence the measured efficacy within an RCT is a reasonable approximation of the true biological efficacy. However, as adherence levels fall, the efficacy measured within a trial substantially under-estimates the true biological efficacy. For example, at 60{\%} adherence, the measured efficacy can be less than half of the true biological efficacy. Conclusion. Poor adherence during a trial can substantially reduce the power to detect an effect, and improved methods of achieving and maintaining high adherence within trials are needed. There are currently 12 ongoing HIV prevention trials, all but one of which require ongoing user-adherence. Attention must be given to methods of maximizing adherence when piloting and designing RCTs and HIV prevention programmes.",
author = "Weiss, {Helen A.} and Wasserheit, {Judith N.} and Barnabas, {Ruanne V.} and Hayes, {Richard J.} and Laith Aburaddad",
year = "2008",
doi = "10.1186/1742-7622-5-8",
language = "English",
volume = "5",
journal = "Emerging Themes in Epidemiology",
issn = "1742-7622",
publisher = "BioMed Central",

}

TY - JOUR

T1 - Persisting with prevention

T2 - The importance of adherence for HIV prevention

AU - Weiss, Helen A.

AU - Wasserheit, Judith N.

AU - Barnabas, Ruanne V.

AU - Hayes, Richard J.

AU - Aburaddad, Laith

PY - 2008

Y1 - 2008

N2 - Background. Only four out of 31 completed randomized controlled trials (RCTs) of HIV prevention strategies against sexual transmission have shown significant efficacy. Poor adherence may have contributed to the lack of effect in some of these trials. In this paper we explore the impact of various levels of adherence on measured efficacy within an RCT. Analysis. We used simple quantitative methods to illustrate the impact of various levels of adherence on measured efficacy by assuming a uniform population in terms of sexual behavior and the binomial model for the transmission probability per partnership. At 100% adherence the measured efficacy within an RCT is a reasonable approximation of the true biological efficacy. However, as adherence levels fall, the efficacy measured within a trial substantially under-estimates the true biological efficacy. For example, at 60% adherence, the measured efficacy can be less than half of the true biological efficacy. Conclusion. Poor adherence during a trial can substantially reduce the power to detect an effect, and improved methods of achieving and maintaining high adherence within trials are needed. There are currently 12 ongoing HIV prevention trials, all but one of which require ongoing user-adherence. Attention must be given to methods of maximizing adherence when piloting and designing RCTs and HIV prevention programmes.

AB - Background. Only four out of 31 completed randomized controlled trials (RCTs) of HIV prevention strategies against sexual transmission have shown significant efficacy. Poor adherence may have contributed to the lack of effect in some of these trials. In this paper we explore the impact of various levels of adherence on measured efficacy within an RCT. Analysis. We used simple quantitative methods to illustrate the impact of various levels of adherence on measured efficacy by assuming a uniform population in terms of sexual behavior and the binomial model for the transmission probability per partnership. At 100% adherence the measured efficacy within an RCT is a reasonable approximation of the true biological efficacy. However, as adherence levels fall, the efficacy measured within a trial substantially under-estimates the true biological efficacy. For example, at 60% adherence, the measured efficacy can be less than half of the true biological efficacy. Conclusion. Poor adherence during a trial can substantially reduce the power to detect an effect, and improved methods of achieving and maintaining high adherence within trials are needed. There are currently 12 ongoing HIV prevention trials, all but one of which require ongoing user-adherence. Attention must be given to methods of maximizing adherence when piloting and designing RCTs and HIV prevention programmes.

UR - http://www.scopus.com/inward/record.url?scp=49549092497&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=49549092497&partnerID=8YFLogxK

U2 - 10.1186/1742-7622-5-8

DO - 10.1186/1742-7622-5-8

M3 - Article

C2 - 18620578

AN - SCOPUS:49549092497

VL - 5

JO - Emerging Themes in Epidemiology

JF - Emerging Themes in Epidemiology

SN - 1742-7622

M1 - 8

ER -